| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/02/2023 | 5.35% | Barclays | $113 → $119 | Maintains | Equal-Weight |
| 08/10/2023 | 46.07% | Tigress Financial | → $165 | Reiterates | Strong Buy → Strong Buy |
| 08/08/2023 | 6.23% | B of A Securities | $110 → $120 | Maintains | Neutral |
| 08/03/2023 | -8.82% | Morgan Stanley | $104 → $103 | Maintains | Equal-Weight |
| 08/03/2023 | 0.04% | Barclays | $106 → $113 | Maintains | Equal-Weight |
| 05/04/2023 | -7.93% | Morgan Stanley | $99 → $104 | Maintains | Equal-Weight |
| 05/04/2023 | -6.16% | Barclays | $101 → $106 | Maintains | Equal-Weight |
| 04/19/2023 | — | Keybanc | Initiates Coverage On | → Sector Weight | |
| 03/03/2023 | 46.07% | Tigress Financial | → $165 | Reiterates | → Strong Buy |
| 02/23/2023 | 1.81% | JP Morgan | $108 → $115 | Maintains | Overweight |
| 02/23/2023 | -12.36% | Morgan Stanley | $91 → $99 | Maintains | Equal-Weight |
| 02/23/2023 | -10.59% | Barclays | $97 → $101 | Maintains | Equal-Weight |
| 11/09/2022 | -14.13% | Barclays | → $97 | Initiates Coverage On | → Equal-Weight |
| 10/17/2022 | -19.44% | Morgan Stanley | $96 → $91 | Maintains | Equal-Weight |
| 08/05/2022 | 46.07% | Tigress Financial | $208 → $165 | Maintains | Strong Buy |
| 08/02/2022 | -3.51% | B of A Securities | $137 → $109 | Downgrades | Buy → Neutral |
| 07/28/2022 | -15.01% | Morgan Stanley | $115 → $96 | Maintains | Equal-Weight |
| 07/28/2022 | 6.23% | JP Morgan | $140 → $120 | Maintains | Overweight |
| 06/15/2022 | 1.81% | Morgan Stanley | $127 → $115 | Maintains | Equal-Weight |
| 03/18/2022 | 23.94% | B of A Securities | $165 → $140 | Upgrades | Neutral → Buy |
| 02/17/2022 | 12.43% | Morgan Stanley | $141 → $127 | Maintains | Equal-Weight |
| 01/05/2022 | 41.64% | Deutsche Bank | $148 → $160 | Upgrades | Hold → Buy |
| 10/28/2021 | 24.82% | Morgan Stanley | $147 → $141 | Maintains | Equal-Weight |
| 07/29/2021 | 30.13% | Morgan Stanley | $138 → $147 | Maintains | Equal-Weight |
| 06/22/2021 | 37.22% | B of A Securities | → $155 | Downgrades | Buy → Neutral |
| 04/29/2021 | 23.94% | Credit Suisse | $129 → $140 | Maintains | Neutral |
| 04/29/2021 | 22.17% | Morgan Stanley | $134 → $138 | Maintains | Equal-Weight |
| 02/18/2021 | 15.08% | Deutsche Bank | $120 → $130 | Maintains | Hold |
| 02/18/2021 | 14.2% | Credit Suisse | $107 → $129 | Maintains | Neutral |
| 02/18/2021 | 18.63% | Morgan Stanley | $123 → $134 | Maintains | Equal-Weight |
| 12/16/2020 | 8.89% | Morgan Stanley | $106 → $123 | Maintains | Equal-Weight |
| 12/08/2020 | 6.23% | Deutsche Bank | → $120 | Initiates Coverage On | → Hold |
| 11/10/2020 | -5.28% | Credit Suisse | $96 → $107 | Maintains | Neutral |
| 10/30/2020 | 6.23% | B of A Securities | $104 → $120 | Upgrades | Underperform → Buy |
| 10/29/2020 | -6.16% | Morgan Stanley | $103 → $106 | Maintains | Equal-Weight |
| 07/31/2020 | -15.01% | Credit Suisse | $91 → $96 | Maintains | Neutral |
| 06/08/2020 | -10.59% | JP Morgan | $92 → $101 | Maintains | Overweight |
| 05/18/2020 | -32.72% | B of A Securities | $85 → $76 | Reiterates | → Underperform |
| 04/30/2020 | -27.41% | Morgan Stanley | $77 → $82 | Maintains | Equal-Weight |
| 04/29/2020 | -15.9% | CFRA | $104 → $95 | Maintains | Hold |
| 03/25/2020 | -31.83% | Morgan Stanley | $100 → $77 | Maintains | Above Average |
| 03/02/2020 | -11.47% | JP Morgan | → $100 | Upgrades | Neutral → Overweight |
| 02/20/2020 | -7.93% | CFRA | $92 → $104 | Maintains | Hold |
| 02/20/2020 | -7.93% | Credit Suisse | $100 → $104 | Maintains | Neutral |
| 02/20/2020 | -11.47% | JP Morgan | $90 → $100 | Maintains | Neutral |
| 02/20/2020 | -11.47% | Morgan Stanley | $85 → $100 | Maintains | Equal-Weight |
| 01/28/2020 | -11.47% | Credit Suisse | $73 → $100 | Upgrades | Underperform → Neutral |
| 10/31/2019 | -24.75% | Morgan Stanley | $81 → $85 | Maintains | Equal-Weight |
| 06/07/2019 | — | JP Morgan | Upgrades | Underweight → Neutral | |
| 02/25/2019 | -37.15% | Credit Suisse | $58 → $71 | Maintains | Underperform |
| 02/21/2019 | — | Longbow Research | Downgrades | Buy → Neutral | |
| 01/07/2019 | -38.03% | Morgan Stanley | $77 → $70 | Maintains | Equal-Weight |
What is the target price for Garmin (GRMN)?
The latest price target for Garmin (NYSE: GRMN) was reported by Barclays on November 2, 2023. The analyst firm set a price target for $119.00 expecting GRMN to rise to within 12 months (a possible 5.35% upside). 13 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Garmin (GRMN)?
The latest analyst rating for Garmin (NYSE: GRMN) was provided by Barclays, and Garmin maintained their equal-weight rating.
When is the next analyst rating going to be posted or updated for Garmin (GRMN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Garmin, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Garmin was filed on November 2, 2023 so you should expect the next rating to be made available sometime around November 2, 2024.
Is the Analyst Rating Garmin (GRMN) correct?
While ratings are subjective and will change, the latest Garmin (GRMN) rating was a maintained with a price target of $113.00 to $119.00. The current price Garmin (GRMN) is trading at is $112.96, which is out of the analyst's predicted range.